ClinicalTrials.gov has a full list of NIAID-funded clinical studies related to RSV.
Researchers have been working toward an RSV vaccine since the 1950s, but no vaccine is yet licensed for use. The best way to prevent RSV is good hygiene and infection-control practices, such as washing your hands frequently with soap and water and avoiding sharing food, cups, or utensils with infected people. Using hand disinfectants will also kill the virus.
Healthcare providers may give infants at high risk for serious RSV infection or complications Synagis (palivizumab). Healthcare providers give such infants Synagis in monthly injections during the entire RSV season, because each injection gives protection for only 30 days.
Last Updated December 01, 2008